BioCentury | Jun 13, 2019
Company News

Complex generic first to show ‘virtual’ bioequivalence with Certara’s modeling system

...the first use of Certara's modeling systems, rather than clinical studies, to demonstrate bioequivalence. The Simcyp...
...by adding in biological pathways that are relevant for disease modification. Elizabeth S. Eaton, Staff Writer Certara Inc. Simcyp Ltd. physiologically-based...
BioCentury | Apr 18, 2018
Translation in Brief

Model combination

...with six other undisclosed partner companies to predict immunogenicity in biologics. Certara also runs the Simcyp...
BioCentury | Mar 31, 2017
Regulation

Stuck in the MIDD-le

...is a drug development consultancy owned by Arsenal Capital Partners . Its offerings include the Simcyp...
...align across industry and with regulators to perform qualification of these models,” he said. The Simcyp...
...companies pay to join the consortium, receive software licenses and vote on priorities for Certara’s Simcyp...
BioCentury | Sep 16, 2013
Company News

Certara, Critical Path Institute deal

...help researchers test new tuberculosis (TB) drugs. The model will work in conjunction with Certara's Simcyp...
BioCentury | Sep 2, 2013
Company News

Certara, The Hamner Institutes for Health Sciences deal

...data. The partners will integrate Hamner's drug-induced liver injury (DILI) modeling software, DILIsym, into Certara's Simcyp...
BioCentury | Mar 5, 2012
Company News

Certara, Simcyp Ltd. deal

...Certara will acquire preclinical modeling company Simcyp for $32 million in cash. Simcyp will become a...
...Livingstone Partners is advising Simcyp and DLA Piper is legal counsel. Details were not disclosed. Simcyp...
...post-tax profits of £1.9 million ($3 million) in 2011. Certara L.P. , St. Louis, Mo. Simcyp Ltd....
BioCentury | Jan 3, 2011
Company News

Simcyp Ltd. sales and marketing update

...for modeling and simulation of drug absorption, distribution, metabolism and excretion in virtual beagle populations. Simcyp Ltd....
BioCentury | Oct 27, 2008
Company News

Simcyp Ltd. sales and marketing update

...Simcyp launched the Simcyp Rat 2008, an in silico animal model for predicting drug kinetics. The...
...for modeling and simulation of drug absorption, distribution, metabolism and excretion in virtual rat populations. Simcyp Ltd....
BioCentury | Jun 2, 2008
Company News

Simcyp Ltd., J&J deal

...J&J’s Johnson & Johnson Pharmaceutical Research and Development subsidiary received a license to Simcyp’s in silico...
...disposition in virtual populations, including children. Financial terms of the three-year contract were not disclosed. Simcyp Ltd....
Items per page:
1 - 9 of 9
BioCentury | Jun 13, 2019
Company News

Complex generic first to show ‘virtual’ bioequivalence with Certara’s modeling system

...the first use of Certara's modeling systems, rather than clinical studies, to demonstrate bioequivalence. The Simcyp...
...by adding in biological pathways that are relevant for disease modification. Elizabeth S. Eaton, Staff Writer Certara Inc. Simcyp Ltd. physiologically-based...
BioCentury | Apr 18, 2018
Translation in Brief

Model combination

...with six other undisclosed partner companies to predict immunogenicity in biologics. Certara also runs the Simcyp...
BioCentury | Mar 31, 2017
Regulation

Stuck in the MIDD-le

...is a drug development consultancy owned by Arsenal Capital Partners . Its offerings include the Simcyp...
...align across industry and with regulators to perform qualification of these models,” he said. The Simcyp...
...companies pay to join the consortium, receive software licenses and vote on priorities for Certara’s Simcyp...
BioCentury | Sep 16, 2013
Company News

Certara, Critical Path Institute deal

...help researchers test new tuberculosis (TB) drugs. The model will work in conjunction with Certara's Simcyp...
BioCentury | Sep 2, 2013
Company News

Certara, The Hamner Institutes for Health Sciences deal

...data. The partners will integrate Hamner's drug-induced liver injury (DILI) modeling software, DILIsym, into Certara's Simcyp...
BioCentury | Mar 5, 2012
Company News

Certara, Simcyp Ltd. deal

...Certara will acquire preclinical modeling company Simcyp for $32 million in cash. Simcyp will become a...
...Livingstone Partners is advising Simcyp and DLA Piper is legal counsel. Details were not disclosed. Simcyp...
...post-tax profits of £1.9 million ($3 million) in 2011. Certara L.P. , St. Louis, Mo. Simcyp Ltd....
BioCentury | Jan 3, 2011
Company News

Simcyp Ltd. sales and marketing update

...for modeling and simulation of drug absorption, distribution, metabolism and excretion in virtual beagle populations. Simcyp Ltd....
BioCentury | Oct 27, 2008
Company News

Simcyp Ltd. sales and marketing update

...Simcyp launched the Simcyp Rat 2008, an in silico animal model for predicting drug kinetics. The...
...for modeling and simulation of drug absorption, distribution, metabolism and excretion in virtual rat populations. Simcyp Ltd....
BioCentury | Jun 2, 2008
Company News

Simcyp Ltd., J&J deal

...J&J’s Johnson & Johnson Pharmaceutical Research and Development subsidiary received a license to Simcyp’s in silico...
...disposition in virtual populations, including children. Financial terms of the three-year contract were not disclosed. Simcyp Ltd....
Items per page:
1 - 9 of 9